Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Toxic epidermal necrolysis associated with carvedilol treatment (CROSBI ID 165945)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Vlahović-Palčevski, Vera ; Milić, Sandra ; Hauser, Goran ; Protić, Alan ; Župan, Željko ; Reljić, Marijana ; Štimac, Davor Toxic epidermal necrolysis associated with carvedilol treatment // International journal of clinical pharmacology and therapeutics, 48 (2010), 8; 549-551

Podaci o odgovornosti

Vlahović-Palčevski, Vera ; Milić, Sandra ; Hauser, Goran ; Protić, Alan ; Župan, Željko ; Reljić, Marijana ; Štimac, Davor

engleski

Toxic epidermal necrolysis associated with carvedilol treatment

Objectivre wos to report a case of fatal toxic epidermal necrolysis associated with carvedilol treatment. Two days after the initiation of carvedilol treatment, a 70-year old woman presented with skin eruptions in the form of maculous rash with blisters that rapidly progressed to epidermal necrolysis. Although the suspected drug was withdrawn, the reaction was extremely rapid in its development with fatal outcome. DISCUSSION: Carvedilol is not a drug commonly associated with TEN. To our knowledge there are no cases of carvedilol related TEN reported in the literature. CONCLUSION: Because of the close temporal relationship between the initiation of carvedilol treatment and the appearance of skin eruptions, and because carvedilol was the only new medication the patient had taken, the etiology of TEN was most likely a reaction to this drug. Physicians should be aware of this extremely rare but serious ADR.

toxic epideraml necrolysis; carvedilol

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

48 (8)

2010.

549-551

objavljeno

0946-1965

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost